Telehealth prescribing flexibilities may be extended by 1 year

The DEA sent a rule titled third temporary extension of pandemic-era telehealth prescribing rules to the White House.

New DEA Rule Expected to Extend Controlled Substance ...

The rule will extend the current DEA telemedicine prescribing flexibilities for at least one more year, possibly two.

Second Temporary Extension of COVID-19 Telemedicine ...

Paragraph (c) is amended to extend the COVID-19 telemedicine prescribing flexibilities from May 12, 2023 through December 31, 2024, provided ...

AHA Requests Flexibility Extension from HHS on DEA Telemedicine ...

The current waivers will expire at the end of the year, and, without an extension of the current waiver or rules implementing a special ...

DEA Likely to Further Extend Flexibilities on Controlled Substances ...

As previously reported, in May 2023 the DEA temporarily extended the COVID-19 telemedicine flexibilities for prescribing controlled substances, ...

As year-end deadline looms, Congress again calls on DEA to ...

With time running short, a third extension on telehealth prescribing flexibilities is needed to allow for a public comment period on the ...

DEA to Extend Telemedicine Prescription Flexibilities?

Subsequently, DEA issued temporary rules in May 2023 and October 2023 extending the telemedicine flexibilities through December 31, 2024 ...

DEA moves to extend telehealth prescribing flexibilities: 7 notes

The Drug Enforcement Administration is signaling that it will extend flexibilities, enacted during the COVID-19 pandemic, that allows healthcare providers to ...

DEA and HHS Extend Telemedicine Flexibilities through 2024

Accordingly, DEA, jointly with the Department of Health and Human Services (HHS), has extended current telemedicine flexibilities through ...

DEA and SAMHSA Extend Telemedicine Flexibilities Again

The First Temporary Rule extended the telemedicine flexibilities for prescribing controlled medications through November 11, 2023. As a result, prescribing ...

DEA to Extend Telehealth Flexibilities for Controlled Substances a ...

Those flexibilities will end Dec. 31, 2024. The resumption of these rules would, among other things, require patients to first be seen in person ...

Lawmakers calls for extending telemedicine flexibilities, object to ...

The proposed rule would reportedly require that no more than half of a prescriber's prescriptions be given through telemedicine. The rule would ...

DEA and HHS Extend Telehealth Prescribing Flexibilities Again

The DEA and DHHS issued the first temporary extension on May 10, 2023, allowing providers to prescribe controlled substances through telehealth to new patients.

Expected Further Extension of COVID-19 Telemedicine Flexibilities ...

11, 2023, but also created a 1 year grace period extending these flexibilities through Nov. 11, 2024, for any practitioner-patient telemedicine relationship ...

DEA extends telehealth prescribing flexibilities through 2024

The Drug Enforcement Administration (DEA) said Friday it will extend telehealth flexibilities that enable clinicians to virtually prescribe controlled ...

Telehealth groups urge feds to extend virtual prescribing flexibilities

Without policy changes, the DEA could curtail current controlled substance prescribing allowances by the end of the year – a "predictable ...

AHA urges DEA and HHS to extend waivers of in-person ...

The AHA Oct. 4 urged the Drug Enforcement Administration and Department of Health and Human Services to extend telehealth flexibilities an ...

DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for ...

The temporary rule will take effect on May 11, 2023, and extends the full set of telemedicine flexibilities adopted during the COVID-19 public health emergency ...

DEA Issues Second Temporary Extension of COVID-19 ...

DEA Issues Second Temporary Extension of COVID-19 Telemedicine Prescribing Flexibilities, Through 2024 ... May 10, 2023 (“First Temporary ...

DEA and HHS Extend Telemedicine Flexibilities for Controlled ...

The First Temporary Rule also included a one-year grace period (through November 11, 2024), that would allow practitioners to prescribe ...